Related references
Note: Only part of the references are listed.The NF-?B multidimer system model: A knowledge base to explore diverse biological contexts
Simon Mitchell et al.
SCIENCE SIGNALING (2023)
KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells
Raffaele Frazzi et al.
ONCOLOGY REPORTS (2022)
The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
Baptiste Eluard et al.
BLOOD (2022)
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
Thomas A. Burley et al.
CANCERS (2022)
RelB contributes to the survival, migration and lymphomagenesis of B cells with constitutively active CD40 signaling
Laura B. Kuhn et al.
FRONTIERS IN IMMUNOLOGY (2022)
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
Ming He et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma
Lorenz Thurner et al.
HAEMATOLOGICA (2021)
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target
Emma Kennedy et al.
BLOOD (2021)
Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL
Marco Haselager et al.
CELL DEATH AND DIFFERENTIATION (2021)
What Will B Will B: Identifying Molecular Determinants of Diverse B-Cell Fate Decisions Through Systems Biology
Simon Mitchell
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study
Nathalie Faumont et al.
FRONTIERS IN ONCOLOGY (2021)
TF-PROTACs Enable Targeted Degradation of Transcription Factors
Jing Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Protocol Standardized flow-cytometry-based protocol to measure factor levels
Bryce A. Manso et al.
STAR PROTOCOLS (2021)
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
Manit Munshi et al.
BLOOD CANCER JOURNAL (2020)
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report
Stuart E. Lacy et al.
BLOOD (2020)
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
George W. Wright et al.
CANCER CELL (2020)
A Regulatory Circuit Controlling the Dynamics of NFκB cRel Transitions B Cells from Proliferation to Plasma Cell Differentiation
Koushik Roy et al.
IMMUNITY (2019)
The LL-100 panel: 100 cell lines for blood cancer studies
Hilmar Quentmeier et al.
SCIENTIFIC REPORTS (2019)
Genetic modification of primary human B cells to model high-grade lymphoma
Rebecca Caeser et al.
NATURE COMMUNICATIONS (2019)
Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling
Man Nie et al.
CLINICAL CANCER RESEARCH (2019)
Microenvironmental Signatures Reveal Biological Subtypes of Diffuse Large B-Cell Lymphoma (DLBCL) Distinct from Tumor Cell Molecular Profiling
Leandro Cerchietti et al.
BLOOD (2019)
NF-κB in the crosshairs: Rethinking an old riddle
Jason Bennett et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
James D. Phelan et al.
NATURE (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nongenetic origins of cell-to-cell variability in B lymphocyte proliferation
Simon Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Aberrant Activation of NF-kappa B Signalling in Aggressive Lymphoid Malignancies
Ruth Kennedy et al.
CELLS (2018)
The non-canonical NF-kappaB Signaling Pathway Contributes to the Expansion and Lymphomagenesis of CD40-activated B Cells
Laura Bernhardine Kuhn et al.
BLOOD (2018)
Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk
Joo Hyun Kim et al.
ONCOTARGET (2017)
Signaling via the NFκB system
Simon Mitchell et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2016)
Oscillation dynamics underlie functional switching of NF-kappa B for B-cell activation
Kentaro Inoue et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2016)
Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP
Yu Wang et al.
ANNALS OF HEMATOLOGY (2015)
Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network
A. Smith et al.
BRITISH JOURNAL OF CANCER (2015)
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies
David W. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A multi-scale approach reveals that NF-κB cRel enforces a B-cell decision to divide
Maxim N. Shokhirev et al.
MOLECULAR SYSTEMS BIOLOGY (2015)
Distinct single-cell signaling characteristics are conferred by the MyD88 and TRIF pathways during TLR4 activation
Zhang Cheng et al.
SCIENCE SIGNALING (2015)
B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma
Ryan M. Young et al.
SEMINARS IN HEMATOLOGY (2015)
Distinct single-cell signaling characteristics are conferred by the MyD88 and TRIF pathways during TLR4 activation
Zhang Cheng et al.
SCIENCE SIGNALING (2015)
NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas
Roser Vento-Tormo et al.
NUCLEIC ACIDS RESEARCH (2014)
A Pathway Switch Directs BAFF Signaling to Distinct NFκB Transcription Factors in Maturing and Proliferating B Cells
Jonathan V. Almaden et al.
CELL REPORTS (2014)
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL
Hendrik Nogai et al.
BLOOD (2013)
U-2932: two clones in one cell line, a tool for the study of clonal evolution
H. Quentmeier et al.
LEUKEMIA (2013)
Pathogenesis of Human B Cell Lymphomas
Arthur L. Shaffer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma
Karin Rydstrom et al.
LEUKEMIA & LYMPHOMA (2012)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Analysis of the coding genome of diffuse large B-cell lymphoma
Laura Pasqualucci et al.
NATURE GENETICS (2011)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Keiichiro Honma et al.
BLOOD (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Frequent inactivation of A20 in B-cell lymphomas
Motohiro Kato et al.
NATURE (2009)
Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy
Seok Jin Kim et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma
Johan Linderoth et al.
LEUKEMIA & LYMPHOMA (2007)
Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness
Juerg Schwaller et al.
BLOOD (2007)
Modulation of NF-κB activity by exchange of dimers
S Saccani et al.
MOLECULAR CELL (2003)
Lymphoid malignancies: The dark side of B-cell differentiation
AL Shaffer et al.
NATURE REVIEWS IMMUNOLOGY (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
